loader image
Friday, December 12, 2025
85.3 F
McAllen
- Advertisement -

Rio Grande Valley’s Second Infusion Center to treat COVID-19 opens in Hidalgo County

Translate to Spanish or other 102 languages!

A second Regional Infusion Center to treat active COVID-19 patients in the Rio Grande Valley is now open in Hidalgo County. Image for illustration purposes

Mega Doctor News

- Advertisement -

EDINBURG, TX – A second Regional Infusion Center to treat active COVID-19 patients in the Rio Grande Valley is now open in Hidalgo County, state and local officials announced Friday.

In a partnership between the Texas Division of Emergency Management (TDEM); Hidalgo County; and DHR Health, the facility is located at 5521 Doctor’s Drive on the campus of the Edinburg-based hospital. The Center will operate seven days a week from 8 a.m. through 5 p.m., administering treatment to residents of the Rio Grande Valley with a capacity to serve 20 patients at a time.

Texas Governor Greg Abbott, who received the treatment himself recently after experiencing a breakthrough case of COVID-19, said:

- Advertisement -

“The State of Texas is proud to partner with local officials and health leaders to launch a second infusion center in the Rio Grande Valley,” said Abbott. “I urge Texans who test positive for COVID-19 to talk to their doctor about receiving this free and effective treatment. Texans can also visit meds.tdem.texas.gov to find a therapeutic provider near them.”

Hidalgo County Judge Richard F. Cortez also was a recipient of this treatment when he contracted COVID-19 last December.

“As someone who has had COVID-19 and received the antibody therapy, I can tell you it is truly a miracle,” said Cortez. “It is quick and in my case it stopped the virus before I developed most symptoms.”

The Regional Infusion Center is the second one that TDEM has opened in the Rio Grande Valley. They first opened on August 14 in Harlingen.

- Advertisement -

The facility will provide monoclonal antibody therapy free of charge to patients with active COVID-19 who meet certain medical conditions and who get a referral from a primary care physician.

These infusion centers, equipped with Regeneron’s monoclonal antibodies, will treat COVID-19 patients who do not need hospitalization with therapeutic drugs that can prevent their condition from worsening and requiring hospital care. These centers also help increase bed capacity in hospitals so that resources are available for the most ill patients. The state deployed similar measures back in November 2020 to communities across Texas. Patients must meet certain criteria and have a referral from a doctor. Patients receiving the treatment will not be charged.

For questions related to the COVID-19 Regional Infusion Center, the public can call 956-362-6843.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Watercress A Nutrient-Dense Leafy Green

Watercress is a leafy green that naturally grows in clean, slow-moving water and belongs to the same plant family as mustard greens, kale, and cabbage. It has a mild, peppery taste and can be eaten raw or cooked in many different meals.

STHS Children’s Receives Visit From Trooper Santa

For the second year in a row, the Texas DPS Troopers Foundation helped spread holiday cheer to hospitalized patients at STHS Children’s during meet & greet with Trooper Santa.

Paxton Sues Medical Records Giant for Blocking Data and Parental Access

Attorney General Ken Paxton filed a lawsuit against Epic Systems Corporation (“Epic”) for their unlawful monopolization of the electronic health records industry and for engaging in deceptive practices that restrict parental access to their minor children’s medical records.

UT Health San Antonio Advances Neurological Care

While much of the focus of tomorrow’s opening of UT Health San Antonio’s Center for Brain Health deservedly is on Alzheimer’s disease, it also marks a major step forward for families as a transformational resource for individuals and families navigating a wide spectrum of neurological and neurodegenerative conditions. Those include complex and rare diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
- Advertisement -
×